Cn / En

CM05291


CM05291

Key word结直肠癌, PDX, 体内药效,体外药效,免疫系统人源化,,

Model Information

Model IDCM05291
Cancer Type结直肠癌
Cell Subtype腺癌
Differentiation中分化
Collection Site右半结肠、右半肝、胆囊
Metastatic Site肝转移
Grade 
TNM stagingypT4bN2aM1a
IHC diagnosisCmet(1+), EGFR(3+), HER2(1+), KI67(>75%+), MLH1(+), MSH2(+), MSH6(+), PMS2(+)
Pathology diagnosis

临床诊断:结肠癌肝转移

诊断意见:

(化疗后)

(右半结肠|右半肝|胆囊):

结肠溃疡型中分化腺癌,肿瘤最大径3cm,肿瘤细胞退变坏死不明显,伴间质纤维化和急慢性炎细胞浸润,符合化疗后改变,NCCN TRG分级:2级;

癌侵至浆膜外,累及小肠固有肌层;

癌侵及阑尾;

未见脉管内癌栓和神经侵犯;

回肠断端、结肠断端和环周切缘未见癌;

大网膜未见癌;

肠周淋巴结可见癌转移(4/18),癌侵至淋巴结被膜外,肠周另见癌结节数枚;

免疫组化结果显示:Cmet(1+),EGFR(3+),HER2(

Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

  

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs